Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 275 of 6351
-
New drug aims to stop rare blood disorder in its tracks
Disease control Not yet recruitingThis is a Phase II, open-label study designed to determine if intravenously administered NM8074 results in remission from TMA in treatment-naïve aHUS patients.
Phase 2 • Sponsor: NovelMed Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a Pre-Surgery drug slash recurrence in rare joint tumors?
Disease control Not yet recruitingTenosynovial giant cell tumor (TGCT) is a rare neoplasm predominantly occurring in young and middle-aged adults, characterized by high recurrence and high disability rates. Surgery represents the first-line treatment at present. Although surgical resection can eradicate lesions, …
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Same-Day HIV treatment: a new weapon against stigma?
Disease control Not yet recruitingThe goal of this study is to develop and implement a same-day ART (SD-ART) protocol for key affected populations with HIV in Peru. The development of the protocol will be guided by asynchronous online focus groups with HIV experts to define eligibility criteria and essential comp…
Sponsor: Yale University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could custom meals lower blood pressure and protect kidneys in veterans?
Disease control Not yet recruitingThis study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned to receive either medically tailored meals or usual care (wait-list control) for 3 months, followed by follow-up/crossove…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
A nudge in time: could text reminders boost alcohol care for cancer patients?
Disease control Not yet recruitingTo assess the potential effects of our multi-level implementation strategies for increasing SBIRT for alcohol use among cancer patients and to refine our methods, the investigators are conducting a pilot-trial with 4 clinics and will be doing interviews with patients and clinicia…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug aims to supercharge walking recovery after spinal cord injury
Disease control Not yet recruitingBreathing brief, moderate bouts of low oxygen trigger (low oxygen therapy, LOT) spinal plasticity (the ability of the nervous system to strengthen neural pathways based on new experiences), and improve walking after spinal cord injury (SCI). The greatest improvements in walking a…
Phase 1/2 • Sponsor: Randy Trumbower, PT, PhD • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Ancient herbal mix could boost liver health in advanced cancer
Disease control Not yet recruitingPrimary liver cancer is a malignant tumor with a very poor prognosis. Hepatocellular carcinoma(HCC) accounts for approximately 80% of cases. Under the current targeted and immunotherapy-based treatment approaches, the overall survival of patients with advanced HCC has improved si…
Phase 2 • Sponsor: Xiang-Qian • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could an arthritis drug stop a deadly skin condition?
Disease control Not yet recruitingCalciphylaxis is a rare but incredibly dangerous condition that causes small blood vessels in the skin to become blocked by calcium buildup and blood clots. This leads to painful skin sores (necrosis) that do not heal easily. Because these open wounds are prone to severe infectio…
Phase 1 • Sponsor: Boston Medical Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
AI chatbot may ease depression and boost well-being in breast cancer survivors
Symptom relief Not yet recruitingthis study aims to develop the Calm-Mind-Recovery-Journey AI-Chatbot delivering BMS-MC therapy for breast cancer survivors and examine its feasibility, acceptability, safety, and preliminary effects of holistic well-being and depressive levels, and coping skills (mindfulness stat…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Can remote care tame COPD Flare-Ups?
Disease control Not yet recruitingThis study is a randomized controlled trial designed to compare the effectiveness of active remote intervention versus passive monitoring alone in patients with Chronic Obstructive Pulmonary Disease (COPD) and chronic hypercapnic respiratory failure who are receiving home non-inv…
Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New device could free AF patients from lifelong blood thinners
Disease control Not yet recruitingThe Conscious Sedation Single Arm Sub-Study is designed to evaluate the safety and performance of the CLAAS device implantation procedure using conscious sedation.
Sponsor: Conformal Medical, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental drug ampligen takes on pancreatic cancer in new trial
Disease control PausedThe purpose of this study is to assess the safety and efficacy of Ampligen in patients with locally advanced pancreatic adenocarcinoma
Phase 2 • Sponsor: AIM ImmunoTech Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
A gel that could help the cervix heal from HPV?
Disease control Not yet recruitingThis randomized, open-label, multicenter clinical study is designed to evaluate Papilozumib® vaginal gel in women aged 30 to 50 years who test positive for human papillomavirus (HPV) and present with either normal cervical cytology or cytological findings of atypical squamous cel…
Sponsor: Hifas da Terra S.L. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
A new 8-Week program aims to boost family care for schizophrenia
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a new support program can improve the quality of informal care for people with schizophrenia in rural China. Informal care means the unpaid care given by family members. Quality of care involves both the care that family members give…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Cannabis extract shows promise for rare genetic disorder in new trial
Symptom relief Not yet recruitingThe FENRTT2 study will investigate the efficacy and safety of a medicinal cannabis plant extract with extremely low THC (delta-9-tetrahydrocannabinol), NTI164, on Rett syndrome (RTT) in a crossover design. RTT is a devastating rare genetic condition affecting females and involves…
Phase 2/3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Sep 10, 2026 03:00 UTC
-
New drug aims to ease bulging eyes in thyroid disease patients
Disease control Not yet recruitingThis is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Phase 3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Digital exercise program aims to boost recovery for breast cancer survivors
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a 12-week hybrid exercise and education program (EmpowerHer) works to improve health-related quality of life in breast cancer survivors aged 35 to 65. The main questions it aims to answer are: * Does the EmpowerHer program improve …
Sponsor: University of Valencia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a structured care pathway lift teen depression in primary care?
Disease control Not yet recruitingProblem statement. Major Depressive Disorder (MDD) is a significant concern among adolescents, characterized by episodes of mood changes, cognitive symptoms, and neurovegetative dysfunction, often lasting months or even years, with a high recurrence rate. In Chile, the prevalence…
Sponsor: Universidad de los Andes, Chile • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo may shrink bleeding plaques in neck arteries, cutting stroke risk
Disease control Not yet recruitingCAROTID-STABILISE is a phase III, multicentre, randomised, double-blind, placebo-controlled trial evaluating whether alirocumab 150 mg subcutaneously every 2 weeks, added to high-intensity statin therapy, produces greater reduction in intraplaque haemorrhage (IPH) volume at 26 we…
Phase 3 • Sponsor: Middle East North Africa Stroke and Interventional Neurotherapies Organization • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can an ultrasound dye replace radiation scans for kidney scarring?
Diagnosis Not yet recruitingIn this research study the investigators want to study a safe, radiation-free technique known as contrast-enhanced ultrasound that may improve the ability to diagnose or evaluate renal scarring compared to regular ultrasound. This technique requires injection into a vein of a sma…
Phase 1 • Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC